Skip to Main Content

Paper Details

Evaluating the impact of age on immune checkpoint therapy biomarkers.
Cell Rep
24
2021
T, T cell, cancer, immune checkpoint genes, interferon gamma, patient, patients, tumor, tumors
Author NameAffiliation
Joanne Xiu
Stephen B BaylinSidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine
Stephen B BaylinSidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine
Claudine IsaacsLombardi Comprehensive Cancer Center, Georgetown University Medical Center
Elizabeth M JaffeeSidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine
Ashani T WeeraratnaSidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Johns Hopkins Bloomberg School of Public Health
Ashani T WeeraratnaSidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Johns Hopkins Bloomberg School of Public Health
Elana J FertigSidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Johns Hopkins University Whiting School of Engineering, Johns Hopkins Bloomberg School of Medicine
  • 1 - 8

Datasets

Release 1.2